Integrating social nutrition principles into the treatment of steatotic liver disease
Dana Ivancovsky‐Wajcman, Paul Brennan, Christopher J. Kopka, Shira Zelber‐Sagi, Zobair M. Younossi, Alina M. Allen, Karen R. Flórez, Jeffrey V. Lazarus
Abstract
Current treatment of metabolic dysfunction-associated steatotic liver disease focuses on adjusting patients’ lifestyles, including promoting weight loss and physical activity. Here, we suggest adopting a holistic preventive hepatology approach encompassing social nutrition, social prescribing and broader societal changes to facilitate individuals’ engagement with behavioural modifications. Ivancovsky-Wajcman et al. outline the need for a holistic preventive hepatology approach, involving social nutrition and social prescribing, to address the public health threat of metabolic dysfunction-associated steatotic liver disease (MASLD). They argue that this will facilitate individuals’ engagement in behavioural modifications to treat MASLD.